Dr Reddy's Laboratories to introduce Molnupiravir to treat COVID-19 shortly

​​The drug firm said it is able to manufacture the active pharmaceutical ingredient (API) as well as the formulation for Molnupiravir, and has made adequate capacity preparations to ensure that it is able to help patients in India as well as in patient populations in need around the world.

via Economictimes